R. D. Hofbauer

Effect of ondansetron, a 5-HT3 receptor antagonist, on the dynamic association between bulimic behaviors and pain thresholds

B. K. Hartman, S. A. Oakman, P. Faris, 1998, Pain.

The Use of Cholecystokinin as an Adjunctive Treatment for Toxin Ingestion

J. Holger, R. D. Hofbauer, 2004, Journal of toxicology. Clinical toxicology.

De-stabilization of the positive vago-vagal reflex in bulimia nervosa

B. K. Hartman, P. Faris, E. Eckert, 2008, Physiology & Behavior.

Ondansetron attenuates CCK induced satiety and c-fos labeling in the dorsal medulla

B. K. Hartman, P. Faris, A. Grossman, 2001, Peptides.

Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial

B. K. Hartman, S. A. Oakman, P. Faris, 2000, The Lancet.

Elevated pain threshold in anorexia nervosa subjects

P. Faris, P. Thuras, E. Eckert, 1999, Biological Psychiatry.

Effect of ondansetron, a 5-HT3 receptor antagonist, on the dynamic association between bulimic behaviors and pain thresholds

B. K. Hartman, S. A. Oakman, Suck-Won Kim, 1998, Pain.